Scribd Logo
Upload

Welcome to Scribd!

  • Former CytoDyn CEO and Clinical Trial Associate Indicted For Defrauding Investors

    Uploaded by

    GeekWire
    4K views42 pages
    The U.S. Department of Justice will prosecute the former CEO of Vancouver, Wash.-based biotech company CytoDyn, Nader Pourhassan, and an associate for allegedly defrauding investors.

    Original Title

    Former CytoDyn CEO and clinical trial associate indicted for defrauding investors

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The U.S. Department of Justice will prosecute the former CEO of Vancouver, Wash.-based biotech company CytoDyn, Nader Pourhassan, and an associate for allegedly defrauding investors.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    4K views42 pages

    Former CytoDyn CEO and Clinical Trial Associate Indicted For Defrauding Investors

    Uploaded by

    GeekWire
    The U.S. Department of Justice will prosecute the former CEO of Vancouver, Wash.-based biotech company CytoDyn, Nader Pourhassan, and an associate for allegedly defrauding investors.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 42

    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 1 of 42

    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 2 of 42


    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 3 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 4 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 5 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 6 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 7 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 8 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 9 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 10 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 11 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 12 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 13 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 14 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 15 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 16 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 17 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 18 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 19 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 20 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 21 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 22 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 23 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 24 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 25 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 26 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 27 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 28 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 29 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 30 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 31 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 32 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 33 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 34 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 35 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 36 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 37 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 38 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 39 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 40 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 41 of 42
    Case 8:22-cr-00440-PX Document 1 Filed 12/15/22 Page 42 of 42

    You might also like